| dc.contributor.author | Wæhre, T | |
| dc.contributor.author | Maagard, A | |
| dc.contributor.author | Tappe, D | |
| dc.contributor.author | et al. | |
| dc.contributor.author | et al. | |
| dc.date.accessioned | 2023-01-13T10:59:09Z | |
| dc.date.available | 2023-01-13T10:59:09Z | |
| dc.date.issued | 2014 | |
| dc.identifier.uri | https://wwwnc.cdc.gov/eid/article/20/8/14-0302_article | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12663/3322 | |
| dc.description.abstract | Zika virus (ZIKV), a member of the family Flaviviridae, is a mosquito-borne virus that is endemic to Africa and Southeast Asia. ZIKV causes illness that is similar to dengue fever, characterized by joint pain, myalgia, headache, and rash (1). ZIKV has caused several recent outbreaks, including one in Micronesia in 2007 (2) and one in French Polynesia (≈30,000 cases) ongoing since October 2013 (3) and spreading to New Caledonia and Easter Island (4). We report the clinical and laboratory findings for a patient with ZIKV infection imported from Tahiti, French Polynesia. | en_US |
| dc.language | English | en_US |
| dc.subject | Zika Research Project | en_US |
| dc.subject | Zika Virus | en_US |
| dc.subject | Zika Virus Infection | en_US |
| dc.subject | Tahiti | en_US |
| dc.title | Zika virus infection after travel to Tahiti, December 2013 | en_US |
| eihealth.country | Others | en_US |
| eihealth.category | Epidemiology and epidemiological studies | en_US |
| eihealth.type | Research protocol information | en_US |
| eihealth.maincategory | Save Lives / Salvar Vidas | en_US |
| dc.relation.ispartofjournal | Emerging Infectious Diseases | en_US |
